Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies

Triple-negative breast cancer (TNBC), characterized by the absence or low expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor (HER2), is the most aggressive subtype of breast cancer. TNBC accounts for about 15% of breast cancer cases in the U....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancers (Basel)
Main Authors: Gupta, Gagan K., Collier, Amber L., Lee, Dasom, Hoefer, Richard A., Zheleva, Vasilena, Siewertsz van Reesema, Lauren L., Tang-Tan, Angela M., Guye, Mary L., Chang, David Z., Winston, Janet S., Samli, Billur, Jansen, Rick J., Petricoin, Emanuel F., Goetz, Matthew P., Bear, Harry D., Tang, Amy H.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2020
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7565566/
https://ncbi.nlm.nih.gov/pubmed/32846967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers12092392
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados